Industries > Pharma > Telemedicine Devices Market 2018-2028

Telemedicine Devices Market 2018-2028

Forecasts and Analysis by Device Type (Telemonitors, Peripheral Devices). Peripheral Devices (Blood Pressure Monitors, Blood Glucose Monitors, Weighing Scales, Pulse Oximeters, Peak Flow Meters, Others) and Geography, with Profiles of Leading Companies

PUBLISHED: 09 February 2018
PAGES: 153
PRODUCT CODE: PHA0285

WOOCS 2.2.1
DOWNLOAD FREE SAMPLE
SKU: PHA0285 Categories: , ,

• Do you need definitive Telemedicine Devices market data?
• Succinct Telemedicine Devices market analysis?
• Technological insight?
• Actionable business recommendations?

Read on to discover how this definitive report can transform your own research and save you time.

The Global Telemedicine Devices market shows immense potential to grow in the future, growing in line with some emerging trends. One such trend is the increasing strategic partnerships in a move to introduce or diversify product portfolios pertaining to the delivery of healthcare.

It is estimated that in 2025, an estimated 1.56 billion adults will be living with hypertension. Telemedicine can help in better management of these diseases as well as help to reduce associated cost. The sickness, disability or death associated with chronic disease can be avoided through preventive measures and use of telemedicine. Moreover, when an older person is diagnosed with a chronic disorder, there is feeling of a loss of freedom and autonomy. Telemedicine can offer a good quality life for such patients at home.

Report highlights

• 88 quantitative tables, charts, and graphs across 153 pages

• Global Telemedicine Devices market outlook and analysis from 2018-2028

• Global Telemedicine Devices submarket forecasts and analysis from 2018-2028
• Telemonitors 
• Peripheral Devices:
– Blood Pressure Monitors
– Blood Glucose Monitors
– Weighing Scales
– Pulse Oximeters
– Peak Flow Meters
– Other Devices

• Key National Telemedicine Devices market forecasts 2018-2028
• US forecast 2018-2028
• Germany forecast 2018-2028
• UK forecast 2018-2028
• France forecast 2018-2028
• Italy forecast 2018-2028
• Spain forecast 2018-2028
• Japan forecast 2018-2028
• Brazil forecast 2018-2028
• Russia forecast 2018-2028
• India forecast 2018-2028
• China forecast 2018-2028
• Brazil forecast 2018-2028

Telemedicine Devices Market 2018-2028

Key questions answered 
• What does the future hold for the Pharmaceutical industry with regards to Telemedicine Devices
• Where should you target your business strategy?
• Which applications should you focus upon?
• Which disruptive technologies should you invest in?
• Which companies should you form strategic alliances with?
• Which company is likely to success and why?
• What business models should you adopt?
• What industry trends should you be aware of?

Target audience
• Leading Pharmaceutical companies
• Suppliers
• Contractors
• Technologists
• R&D staff
• Consultants
• Analysts
• CEO’s
• CIO’s
• COO’s
• Business development managers
• Investors
• Governments
• Agencies
• Banks

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Telemedicine Devices Market 2018-2028


Download sample pages

Complete the form below to download your free sample pages for Telemedicine Devices Market 2018-2028


Latest Pharma news

Visiongain Publishes Pharma Wholesale and Distribution Market Report 2022-2032

The pharma wholesale and distribution market was valued at US$511.80 billion in 2021 and is projected to grow at a CAGR of 7.84% during the forecast period 2022-2032.

29 September 2022

READ

Visiongain Publishes Mesenchymal Stem Cells Market Report 2022-2032

The mesenchymal stem cells market was valued at US$2.44 billion in 2021 and is projected to grow at a CAGR of 13.82% during the forecast period 2022-2032.

21 September 2022

READ

Visiongain Publishes Advanced Wound Care Management Market Report 2022-2032

The global advanced wound care management market is estimated to be valued at US$12,581.3 million in 2022. The market is projected to reach a market value of US$23,307.5 million by 2032 and is projected to grow at a CAGR of 6.36% during the forecast period 2022-2032.

16 September 2022

READ

Visiongain Publishes Gene Therapy R&D Market Report 2022-2032

The gene therapy R&D market was valued at US$1,653.0 million in 2021 and is projected to grow at a CAGR of 30.1% during the forecast period 2022-2032.

15 September 2022

READ